x-octo home Business judgment on AI products
中文

Real-revenue cases

How I Expanded My CBD Product Line And Became A White Label

Real demand

A founder who started with his own CBD brand pivoted into contract manufacturing, winning brand clients by undercutting their existing COGS, and now self-reports $74K in monthly revenue.

Founder interview, self-reported 行业人脉转介创始人社群Instagram邮件
Primary source
View original

01

Real-demand verdict

Real-demand verdict

Real demand

These clients were already paying for the same goods elsewhere and simply switched suppliers on price; the demand is an existing purchasing behavior, not a newly invented one.

How it makes money

Charges brand clients for contract and white-label manufacturing of CBD/hemp products, billed per batch or contract, while keeping residual revenue from its own product line.

What old behavior it replaces

Brands' previous, more expensive contract manufacturers (and some in-house production).

02

Where the first customers came from

An industry contact noticed their cost of goods undercut the contact's current pricing by 400%, which brought the first manufacturing clients; earlier acquisition details are not covered.

Acquisition channels 行业人脉转介创始人社群Instagram邮件

03

Tactics you can copy

  1. 01Lead with a cost gap: price out the prospect's current supplier, then quote visibly lower with a spec comparison attached (e.g. half the price, higher potency).
  2. 02Bundle manufacturing into white-label: logo, 3D renders, website, lab testing, QR codes, stickers and custom formulation sold together to raise deal size.
  3. 03Deliberately thin margins to win larger contracts and keep capacity utilized.
Moving it to an AI business

For AI businesses: the pattern of pricing out the incumbent supplier, entering with a visibly lower unit cost, and bundling adjacent work into a white-label offer transfers directly to white-label AI services (support bots, content generation, fine-tuned model delivery) — the key is making your cost structure a comparable number.

04

Evidence and limits

Self-reported numbers are unaudited — treat them as leads, not facts
Founder interview, self-reported

Revenue basis · Founder self-reported, unaudited (see source page)

What evidence is missing

The $74K monthly figure is founder self-reported, unaudited, and the basis (revenue vs. gross margin) is unspecified.
Claims of 400% cost advantage, 800% potency increase and 50% price cuts are one-sided with no third-party or client-side evidence.
The TJ-Maxx-linked warehouse and gummy line are still in negotiation and should not be counted as realized revenue.